Approval · Notice of Compliance 9508 · 2008
PHL-ISMN: Notice of Compliance 9508
Issued April 23, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9508
- Date
- April 23, 2008
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antianginal agent
- Canadian reference product
- IMDUR (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHL-ISMN | 02307731 | Cancelled Pre Market |
Medicinal ingredients
- ISOSORBIDE-5-MONONITRATE 60 MG per TAB